National Hospital Organization Kagoshima Medical Center

Kagoshima 892-0853

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Ischemic Stroke; Ischemic Attack, Transient, Leukemia

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) — Completed